Semaglutide

GLP-1 Receptor Agonist

R 1 690,50/ pen

A once-weekly GLP-1 receptor agonist. Semaglutide mimics the body's own GLP-1 hormone to quiet appetite, slow gastric emptying, and improve insulin sensitivity — clinically proven to reduce body weight by an average of 15%.

ConcentrationSemaglutide 4.33mg / 2.6ml

Dosage0.25mg–1.08mg once a week

Pen strength

Check eligibility →Ask a pharmacist

Prescription medicine — dispensed only after doctor approval. Payment is held until your protocol is approved.

Prescription-only compounded medicine, dispensed only after a doctor reviews your assessment. Store refrigerated (2–8°C).

Key benefits

See the science +

Acts on hypothalamic receptors to reduce hunger and quiet food noise, making a sustainable calorie deficit far easier to hold.

How to Use

A once-weekly subcutaneous injection with the pre-filled DOSIST pen. Your dose is titrated upward from 0.25mg under prescriber guidance to minimise side effects; your doctor confirms the right pen strength at review.

Formulation

Sterile, pharmacy-compounded solution — Semaglutide 4.33mg (1.08mg pen) or 8.67mg (2.17mg pen) per 2.6ml pen, pre-filled and cold-chain dispatched.

Pharmacist-compounded

SAHPRA compliant

Doctor-reviewed

Cold-chain delivery